These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10091907)

  • 1. Combining summaries of binary outcomes with those of continuous outcomes in a meta-analysis.
    Whitehead A; Bailey AJ; Elbourne D
    J Biopharm Stat; 1999 Mar; 9(1):1-16. PubMed ID: 10091907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of ordinal outcomes using individual patient data.
    Whitehead A; Omar RZ; Higgins JP; Savaluny E; Turner RM; Thompson SG
    Stat Med; 2001 Aug; 20(15):2243-60. PubMed ID: 11468762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.
    Mitchell GG; Elbourne DR
    Online J Curr Clin Trials; 1993 Aug; Doc No 83():[2305 words; 32 paragraphs]. PubMed ID: 8306013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. Prophylactic oxytocin: Before or after placental delivery?
    Kahn S; Meyer A; Beste J; Flake D
    J Fam Pract; 2008 Dec; 57(12):817-8. PubMed ID: 19080766
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining multiple outcome measures in a meta-analysis: an application.
    Arends LR; Vokó Z; Stijnen T
    Stat Med; 2003 Apr; 22(8):1335-53. PubMed ID: 12687658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
    Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
    Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the relationship between surrogates and clinical outcomes: analysis of individual patient data vs. meta-regression on group-level summary statistics.
    Li Z; Meredith MP
    J Biopharm Stat; 2003 Nov; 13(4):777-92. PubMed ID: 14584722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach by Yutaka Matsuyama, Statistics in Medicine 2002; 21:675-687.
    Lui KJ
    Stat Med; 2007 Nov; 26(25):4679-83. PubMed ID: 17278185
    [No Abstract]   [Full Text] [Related]  

  • 14. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
    Warn DE; Thompson SG; Spiegelhalter DJ
    Stat Med; 2002 Jun; 21(11):1601-23. PubMed ID: 12111922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-outcome meta-analysis of clinical trials.
    Berkey CS; Anderson JJ; Hoaglin DC
    Stat Med; 1996 Mar; 15(5):537-57. PubMed ID: 8668877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should active management of the third stage of labor be routine?
    Nothnagle M; Taylor JS
    Am Fam Physician; 2003 May; 67(10):2119-20. PubMed ID: 12776960
    [No Abstract]   [Full Text] [Related]  

  • 17. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials.
    Guru V; Omura J; Alghamdi AA; Weisel R; Fremes SE
    Circulation; 2006 Jul; 114(1 Suppl):I331-8. PubMed ID: 16820596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of re-randomized data in meta-analysis.
    Hozo I; Djulbegovic B; Clark O; Lyman GH
    BMC Med Res Methodol; 2005 May; 5():17. PubMed ID: 15882470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol for the prevention and treatment of postpartum haemorrhage.
    Hofmeyr GJ; Gülmezoglu AM
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1025-41. PubMed ID: 18786863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of postpartum hemorrhage, safety and efficacy.
    Abu-Omar AA
    Saudi Med J; 2001 Dec; 22(12):1118-21. PubMed ID: 11802188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.